Cytogen Balance Sheet Health
Financial Health criteria checks 5/6
Cytogen has a total shareholder equity of ₩54.6B and total debt of ₩12.6B, which brings its debt-to-equity ratio to 23.1%. Its total assets and total liabilities are ₩75.6B and ₩21.0B respectively.
Key information
23.1%
Debt to equity ratio
₩12.60b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩52.19b |
| Equity | ₩54.57b |
| Total liabilities | ₩21.04b |
| Total assets | ₩75.61b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: A217330's short term assets (₩55.7B) exceed its short term liabilities (₩3.2B).
Long Term Liabilities: A217330's short term assets (₩55.7B) exceed its long term liabilities (₩17.8B).
Debt to Equity History and Analysis
Debt Level: A217330 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if A217330's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A217330 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: A217330 has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 13% each year